Pascal Biosciences Stock Forecast, Price & News

Pascal Biosciences (CVE:PAS) Frequently Asked Questions

What stocks does MarketBeat like better than Pascal Biosciences?

Wall Street analysts have given Pascal Biosciences a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Pascal Biosciences wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has Pascal Biosciences' stock price been impacted by COVID-19?

Pascal Biosciences' stock was trading at C$0.10 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, PAS stock has decreased by 15.0% and is now trading at C$0.09.
View which stocks have been most impacted by COVID-19.

Who are Pascal Biosciences' key executives?

Pascal Biosciences' management team includes the following people:

• Dr. Patrick W. Gray, CEO & Director (Age 69, Pay $223.48k)
• Mr. Kevin M. Egan M.B.A., Chief Bus. Officer
• Mr. Mark Adrian Van der Horst, Pres (Age 54)
• Mr. Harold H. Forzley C.A., Chief Financial Officer (Age 68)

Who are some of Pascal Biosciences' key competitors?

Some companies that are related to Pascal Biosciences include Liberty Biopharma (LTY), Bioasis Technologies (BTI), Hemogenyx Pharmaceuticals (HEMO), AorTech International (AOR), Kane Biotech (KNE), ImmuPharma (IMM), Midatech Pharma (MTPH), Crescita Therapeutics (CTX), Hvivo (HVO), Quest PharmaTech (QPT), Realm Therapeutics (RLM), Biopharmx (BPMX), Hemostemix (HEM), Ovoca Bio (OVB) and Medicure (MPH).
View all of PAS's competitors.

What other stocks do shareholders of Pascal Biosciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Pascal Biosciences investors own include Aurora Cannabis (ACB), Canadian Natural Resources (CNQ), Corus Entertainment (CJR), Auxly Cannabis Group (CBWTF), Grande West Transportation Group (BUS), Bausch Health Companies (BHC), Abattis Bioceuticals (ATT), Algonquin Power & Utilities (AQN), Aphria (APHA) and Abacus Mining & Exploration (AME).

What is Pascal Biosciences' stock symbol?

Pascal Biosciences trades on the Canadian Venture Exchange (CVE) under the ticker symbol "PAS."

How do I buy shares of Pascal Biosciences?

Shares of PAS and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Pascal Biosciences' stock price today?

One share of PAS stock can currently be purchased for approximately C$0.09.

How much money does Pascal Biosciences make?

Pascal Biosciences has a market capitalization of C$5.53 million.

How many employees does Pascal Biosciences have?

Pascal Biosciences employs 6 workers across the globe.

What is Pascal Biosciences' official website?

The official website for Pascal Biosciences is www.biommune.net.

Where are Pascal Biosciences' headquarters?

Pascal Biosciences is headquartered at 400 Burrard St Suite 1780, VANCOUVER, BC V6C 3A6, Canada.

How can I contact Pascal Biosciences?

Pascal Biosciences' mailing address is 400 Burrard St Suite 1780, VANCOUVER, BC V6C 3A6, Canada. The company can be reached via phone at +1-604-6886775.